IPSEF

ABBV AMGN AMGN:CA BAYRY BAYZF Biotechnology BMY GILD IPSEF IPSEY JNJ JNJ:CA LLY LLY:CA NONOF NOVO:CA NVO NVON:CA NVS NVS:CA NVSEF PFE PFE:CA REGN RHHBF RHHBY RHHVF Robert J. Lake ROCH:CA ROG:CA SAN:CA SNY SNY:CA SNYNF Uncategorized VRTX ZLLY:CA ZPFE:CA

Regeneron: Fairly Valued Now After A Stellar Upswing

Mar 11, 2026

ABBV ABBV:CA Biotechnology DAWN IPSEF IPSEY JAZZ LLY LLY:CA Terry Chrisomalis Uncategorized WHWK ZLLY:CA

Day One Biopharmaceuticals: ‘Strong Buy,’ Several 2026 Milestones In Play Plus OJEMDA Growth

Mar 5, 2026

ALLKA Research Biotechnology GILD GILD:CA GLAXF GNFTF GNFTY GSK IPSEF IPSEY JNJ JNJ:CA MRK MRK:CA Uncategorized

Time To Take Profits On Gilead Sciences (Rating Downgrade)

Feb 20, 2026

Biotechnology GNFTF GNFTY IPSEF IPSEY Uncategorized

Genfit adds $20M as Ipsen records strong sales for liver drug

Feb 12, 2026